Abstract:Abstract Background Ovarian cancer (OC) is the most lethal gynaecological tumor. Changes in glycolysis have been proven to play an important role in OC progression. We aimed to identify a novel glycolysis-related gene signature to better predict the prognosis of patients with OC. Methods mRNA and clinical data were obtained from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype Tissue Expression (GTEx) database. The “limma” R package was used to identify glycolysis-related differentially expressed genes (DEGs). Then, a multivariate Cox proportional regression model and survival analysis were used to develop a glycolysis-related gene signature. Furthermore, the TCGA training set was divided into two internal test sets for validation, while the ICGC dataset was used as an external test set. A nomogram was constructed in the training set, and the relative proportions of 22 types of tumor-infiltrating immune cells were evaluated using the “CIBERSORT” R package. The enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were determined by single-sample gene set enrichment analysis (ssGSEA) with the “GSVA” R package. Finally, the expression and function of the unreported signature genes ISG20 and SEH1L were explored using immunohistochemistry, western blotting, qRT-PCR, proliferation, migration, invasion and xenograft tumor assays. Results A five-gene signature comprising ANGPTL4, PYGB, ISG20, SEH1L and IRS2 was constructed. This signature could predict prognosis independent of clinical factors. A nomogram incorporating the signature and three clinical features was constructed, and the calibration plot suggested that the nomogram could accurately predict the survival rate. According to ssGSEA, the signature was associated with KEGG pathways related to axon guidance, mTOR signalling, tight junctions, etc. The proportions of tumor-infiltrating immune cells differed significantly between the high-risk group and the low-risk group. The expression levels of ISG20 and SEH1L were lower in tumor tissues than in normal tissues. Overexpression of ISG20 or SEH1L suppressed the proliferation, migration and invasion of Caov3 cells in vitro and the growth of xenograft tumors in vivo. Conclusion Five glycolysis-related genes were identified and incorporated into a novel risk signature that can effectively assess the prognosis and guide the treatment of OC patients.

A VEGF-dependent Gene Signature Enriched in Mesenchymal Ovarian Cancer Predicts Patient Prognosis

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

An Integrated Model of Clinical Information and Gene Expression for Prediction of Survival in Ovarian Cancer Patients

Novel Gene Signatures for Prognosis Prediction in Ovarian Cancer.

[Expressions of VEGF/VEGFRs and Activation of STATs in Ovarian Carcinoma].

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis

Construction and validation of a comprehensive metabolism-associated prognostic model for predicting survival and immunotherapy benefits in ovarian cancer

A compact VEGF signature associated with distant metastases and poor outcomes

Identification and Analysis of in Vivo Vegf Downstream Markers Link Vegf Pathway Activity with Efficacy of Anti-Vegf Therapies

Functional Significance of VEGF-a in Human Ovarian Carcinoma: Role in Vasculogenic Mimicry.

Identification of a Glycolysis‐related Gene Signature for Survival Prediction of Ovarian Cancer Patients

The Expression of VEGF and Dll4/Notch Pathway Molecules in Ovarian Cancer

Total and Not Bevacizumab-Bound Vascular Endothelial Growth Factor As Potential Predictive Factors to Bevacizumab-Based Chemotherapy in Colorectal Cancer.

Correlation of Serum VEGF Levels with Clinical Stage, Therapy Efficacy, Tumor Metastasis and Patient Survival in Ovarian Cancer.

Multiple Genetic Variants Predict the Progression-Free Survival of Bevacizumab Plus Chemotherapy in Advanced Ovarian Cancer

Establishment and validation of a prognostic model based on grouping of vasculogenic mimicry-related genes in ovarian cancer

Prognostic Significance of Differential Expression of Angiogenic Genes in Women with High-Grade Serous Ovarian Carcinoma

Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer

The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis.

A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer

Clinical significance and immune infiltration analyses of a novel coagulation-related signature in ovarian cancer